The classic guide to all major prescription and nonprescription drugs, featuring revised, up-to-date FDA information and an A–Z list of illnesses for easy reference. Includes coverage of dosage and length of time before a drug takes effect; side effects; special precautions; interactions with other food and drugs; standards for use by different age groups; and more. From the Trade Paperback edition.

The revised and updated 2011 edition of the most accessible, comprehensive and affordable guide to prescription and nonprescription drugs. The classic guide to all major prescription and nonprescription drugs, featuring revised, up-to date FDA information and an A-Z list of medical conditions and their commonly used drugs for easy reference. It includes coverage of dosage and length of time before the drug takes effect, side effects, special precautions, interactions with other food and drugs, standards for use by different age groups, and much more. It also features a generic and brand name directory, a comprehensive glossary, and complete index by generic, brand, and class name.

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.

Written and peer reviewed by experts in practice and academia, the 19th edition of the Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care is an authoritative resource for students and for health care providers who counsel and care for patients undertaking self-treatment¿nonprescription drugs, nutritional supplements, medical foods, nondrug and preventive measures, and complementary therapies. Its goal is to develop the knowledge and problem-solving skills needed to assess a patient¿s health status and current practice of self-treatment, to determine whether self-care is necessary or appropriate, and, if appropriate, to recommend safe and effective self-care measures.

IF YOU TAKE NUTRITIONAL SUPPLEMENTS, HERBS, VITAMINS, AND OTHER NATURAL PRODUCTS, YOU NEED THIS BOOK! Compiled by one of America’s leading authorities on natural medicine, The Pill Book Guide to Natural Medicines answers vital questions about the effectiveness and safety of more than 250 of today’s most popular natural remedies. Dr. Murray's unique A-to-F rating system tells you at a glance whether the product has been scientifically proven to work and if there are risks in taking it. Written in clear, accessible language, here is important information on: • What the product is for, and how it works • Safety and effectiveness rating • Possible side effects • Drug and food interactions • Usual dosage • Cautions and warnings • Special concerns for seniors, children, and pregnant women Up-to-date and authoritative, The Pill Book Guide to Natural Medicines also contains Dr. Murray's recommendations for the prevention and treatment of over 70 common conditions, from acne and atherosclerosis to ulcers and varicose veins. Remember, just because a product is “natural” does not mean it is safe. This important reference can help you make wise choices–or even save your health.

The classic guide to all major prescription and nonprescription drugs, featuring revised, up-to-date FDA information and an A–Z list of illnesses for easy reference. Includes coverage of dosage and length of time before a drug takes effect; side effects; special precautions; interactions with other food and drugs; standards for use by different age groups; and more.

Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.

Includes 25 new diagnoses and digital updates as needed! The only prescribing guide conveniently organized by clinical diagnoses for adult and pediatric patients, this concise resource is an unrivaled reference tool for advanced health care providers (AHCPs) and students in all clinical practice settings who need guidance on prescribing drugs for patients with acute, episodic, and chronic health problems. Newly updated for 2022 with the most recent drug information and clinical guidance, this revised edition contains 25 new diagnoses including 15 additional cancer diagnoses and the novel Coronavirus (COVID-19). The APRN and PA's Complete Guide to Prescribing Drug Therapy 2022 intersperses clinically useful information throughout, such as monitored laboratory values, patient teaching points, and safety information. Section I alphabetically presents pharmacotherapy regimens for more than 600 clinical diagnoses. Each diagnosis contains drug choices alphabetically by generic name, FDA pregnancy category, OTC availability, generic availability, adult and pediatric dosing regimens, brand/trade names, available dose forms, and additive information. Section II uses a convenient table format to convey pediatric and adult immunization schedules, contraceptives, pediatric dosing tables for liquid anti infectives, and much more. An alphabetical cross reference index of drugs by generic and brand/trade names, with FDA pregnancy category and controlled drug schedule, facilitates quick identification of drugs by alternate names and relative safety during pregnancy. Key Features: Uniquely organized by clinical diagnosis! Addresses drug treatment options for over 600 specific diagnoses Guides the AHCP through drug classes, categories, and brand/trade names for primary care health issues Contains over 30 Appendices with quick access to drugs by category (e.g., antineoplastics, anticonvulsants), child and adult immunization schedules, contraceptives by form, glucocorticosteroids by potency, and much more! Index provides cross referencing of drugs by generic and brand/trade names Includes eBook and regular updates with purchase of print guide

This is thirty-fifth edition of Martindale, which provides reliable, and evaluated information on drugs and medicines used throughout the world. It contains encyclopaedic facts about drugs and medicines, with: 5,500 drug monographs; 128,000 preparations; 40,700 reference citations; 10,900 manufacturers. There are synopses of disease treatments which enables identification of medicines, the local equivalent and the manufacturer. It also Includes herbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins, and poisons as well as drugs and medicines. Based on published information and extensively referenced